161 related articles for article (PubMed ID: 12071933)
1. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2000 Mar; 64(3):188-93. PubMed ID: 10997885
[TBL] [Abstract][Full Text] [Related]
3. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
4. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Lindstedt G; Stockelberg D; Wadenvik H; Kutti J
Leuk Lymphoma; 2001 May; 41(5-6):579-84. PubMed ID: 11378575
[TBL] [Abstract][Full Text] [Related]
5. Increase of CD34 positive cells in polycythaemia vera.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 1997 Sep; 59(3):171-6. PubMed ID: 9310125
[TBL] [Abstract][Full Text] [Related]
6. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
7. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.
Carneskog J; Kutti J; Wadenvik H; Lundberg PA; Lindstedt G
Eur J Haematol; 1998 May; 60(5):278-82. PubMed ID: 9654156
[TBL] [Abstract][Full Text] [Related]
8. Clinico-Pathological Profile And Outcomes Of Patients With Polycythaemia Vera, Essential Thrombocythaemia And Idiopathic Myelofibrosis: A Tertiary Care Center Experience From Southern Pakistan.
Shaikh MS; Shaikh MU; Adil SN; Khurshid M; Ahmed ZA
J Ayub Med Coll Abbottabad; 2016; 28(2):293-297. PubMed ID: 28718562
[TBL] [Abstract][Full Text] [Related]
9. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
Kornberg A; Fibach E; Treves A; Goldfarb A; Rachmilewitz EA
Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
[TBL] [Abstract][Full Text] [Related]
10. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
Dai C; Chung IJ; Krantz SB
Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.
Delhommeau F; Dupont S; Tonetti C; Massé A; Godin I; Le Couedic JP; Debili N; Saulnier P; Casadevall N; Vainchenker W; Giraudier S
Blood; 2007 Jan; 109(1):71-7. PubMed ID: 16954506
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
Passamonti F; Vanelli L; Malabarba L; Rumi E; Pungolino E; Malcovati L; Pascutto C; Morra E; Lazzarino M; Cazzola M
Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
[TBL] [Abstract][Full Text] [Related]
13. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis.
Ciurea SO; Merchant D; Mahmud N; Ishii T; Zhao Y; Hu W; Bruno E; Barosi G; Xu M; Hoffman R
Blood; 2007 Aug; 110(3):986-93. PubMed ID: 17473062
[TBL] [Abstract][Full Text] [Related]
14. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
15. Differences among myeloproliferative disorders in the behavior of their restricted progenitor cells in culture.
Croizat H; Amato D; McLeod DL; Eskinazi D; Axelrad AA
Blood; 1983 Sep; 62(3):578-84. PubMed ID: 6603877
[TBL] [Abstract][Full Text] [Related]
16. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
[TBL] [Abstract][Full Text] [Related]
17. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders.
Battegay EJ; Thomssen C; Nissen C; Gudat F; Speck B
Eur J Haematol; 1989 Apr; 42(4):321-6. PubMed ID: 2656291
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
Johansson P; Andréasson B
Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
[TBL] [Abstract][Full Text] [Related]
19. Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
Andréasson B; Carneskog J; Lindstedt G; Lundberg PA; Swolin B; Wadenvik H; Kutti J
Leuk Lymphoma; 2000 Mar; 37(1-2):189-95. PubMed ID: 10721786
[TBL] [Abstract][Full Text] [Related]
20. The effects of IL-1 and IL-4 on the Epo-independent erythroid progenitor in polycythaemia vera.
de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E
Br J Haematol; 1994 Oct; 88(2):242-6. PubMed ID: 7803266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]